Drug Facts

Manufacturer
Sandoz Inc
Effective date
2025-06-30
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
daily-update
Hydrated at
2026-06-03 18:03:35

Label at a glance#

ProductCetirizine Hydrochloride
Active ingredientCETIRIZINE HYDROCHLORIDE
Label structure8 sections

Indications and uses

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • itching of the nose or throat

Dosage and administration

• may be taken with or without water • chew or crush tablets completely before swallowing adults and children 6 years and over 1 to 2 tablets once daily; depending upon severity of symptoms; do not take more than 2 tablets in 24 hours adults 65 years and over 1 tablet once a day; do not take more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a docto...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

(in each chewable tablet)

Cetirizine HCl 5 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings

WARNINGS SECTION

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives.

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery
  • in rare cases, you may experience itching after stopping cetirizine. Consult your healthcare provider if this happens.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • may be taken with or without water
  • chew or crush tablets completely before swallowing

adults and children 6 years and over

1 to 2 tablets once daily; depending upon severity of symptoms; do not take more than 2 tablets in 24 hours

adults 65 years and over

1 tablet once a day; do not take more than 1 tablet in 24 hours

children under 6 years of age

ask a doctor

consumers with liver or kidney disease

ask a doctor

Other information

SPL UNCLASSIFIED SECTION

Store between 20ºC to 25º C (68ºF to 77º F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

acesulfame potassium, artificial flavors, benzyl alcohol, betadex, colloidal silicon dioxide, dl-alpha-tocopherol, ferric oxide red, ferric oxide yellow, lactose monohydrate, magnesium stearate, maltodextrin, microcrystalline cellulose, propylene glycol, talc and tutti frutti flavor.

Questions? 1-800-525-8747

Manufactured by

Sandoz Private Limited, India

for Sandoz Inc., Princeton, NJ 08540

Product of India

Revised: 04/2026

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0781-5283-64

Children's

Cetirizine HCl Chewable Tablets

5 mg

antihistamine

Tutti Frutti Flavored

30 Chewable Tablets

Do not use if individual blister unit is open or torn

ALLERGY

Indoor & Outdoor Allergies

6 years and older

5 mg each

24 hour Relief of

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat or Nose
  • Actual Size
  • No water needed

Chew or crush tablets completely before swallowing

cetirizine5mg
cetirizine5mg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1014643cetirizine HCl 5 MG Chewable TabletPSN8
1014643cetirizine hydrochloride 5 MG Chewable TabletSCD8

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CETIRIZINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c505bb17-4ff9-45f9-ac2d-bb9c8c9d35beProduct name120200304
a255659f-db40-429d-8c07-5f173f330d9cProduct name120190402

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-5283-06EA - Each0781-52839597b375-16fa-45e7-bd32-2b8a665b5ed312018-11-06
0781-5283-64EA - Each0781-5283769a8519-0fc0-46fb-9d34-27d6048503bb12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CETIRIZINE HYDROCHLORIDEACTIVE INGREDIENT64O047KTOA2
CETIRIZINEACTIVE MOIETYYO7261ME242
.ALPHA.-TOCOPHEROL ACETATE, DL-INACTIVE INGREDIENTWR1WPI7EW82
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G92
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBH2
BETADEXINACTIVE INGREDIENTJV039JZZ3A2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6752
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRT2
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5X2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2D2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU42
TALCINACTIVE INGREDIENT7SEV7J4R1U2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0781-52830781-5283-06, 0781-5283-64

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML · Source PDF

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-10-09full-release2026-06-01 00:54:08

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 114 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE / ORAL1072 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii+route
60 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET / ORAL1.06 mgExact identifier — unii+route
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, EXTENDED RELEASE / ORAL9 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii+route
60 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE, EXTENDED RELEASE / ORAL1.23 mgExact identifier — unii+route
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
60 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / ORAL100 mgExact identifier — unii+route
18 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, CHEWABLE / ORAL14 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii+route
60 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE, DL-.ALPHA.-TOCOPHEROL ACETATE, DL-WR1WPI7EW8OINTMENT / TOPICALNAExact identifier — unii candidate
6 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
ACESULFAME POTASSIUMACESULFAME POTASSIUM23OV73Q5G9TABLET, CHEWABLE / ORAL15 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii+route
60 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii+route
60 equally ranked IID candidates
MALTODEXTRINMALTODEXTRIN7CVR7L4A2DTABLET, CHEWABLE / ORAL292 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, CHEWABLE / ORAL127 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii+route
60 equally ranked IID candidates
.ALPHA.-TOCOPHEROL ACETATE, DL-.ALPHA.-TOCOPHEROL ACETATE, DL-WR1WPI7EW8OINTMENT / TOPICALNAExact identifier — unii candidate
6 equally ranked IID candidates
LACTOSE MONOHYDRATELACTOSE MONOHYDRATEEWQ57Q8I5XTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE / ORAL450 mgExact identifier — unii+route
18 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE / ORAL450 mgExact identifier — unii+route
18 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, CHEWABLE / ORAL254 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii+route
60 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, CHEWABLE / ORAL1725 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, EXTENDED RELEASE / ORAL9 mgExact identifier — unii+route
60 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET, DELAYED RELEASE / ORAL2.31 mgExact identifier — unii+route
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
60 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, CHEWABLE / ORAL14 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii+route
60 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / ORAL360 mgExact identifier — unii+route
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / ORAL27120 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii+route
60 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LIQUID / ORAL29008 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / ORAL27120 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii+route
60 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, COATED / ORAL25 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE / ORAL1072 mgExact identifier — unii+route
60 equally ranked IID candidates
BETADEXBETADEXJV039JZZ3ATABLET, CHEWABLE / ORAL85 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / ORAL100 mgExact identifier — unii+route
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii+route
60 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii+route
60 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / ORAL360 mgExact identifier — unii+route
18 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, CHEWABLE / ORAL1725 mgExact identifier — unii+route+dosage form
3 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYCETIRIZINE HYDROCHLORIDE5MGTABLET, CHEWABLE / ORAL2008-02-14
A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGYCETIRIZINE HYDROCHLORIDE10MGTABLET, CHEWABLE / ORALRS2008-02-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-1484e616aacf4f…
2026-09-14 22:38:342026-08A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-1484e616aacf4f…
2026-08-18 06:07:402026-07A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14caaa826d4ba7…
2026-08-18 06:07:402026-07A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-1403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-142680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-145bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14d06236e962d9…
2024-10-29 15:01 UTC2024-10A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-1479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-14301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-141e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-148072bd15b7f6…
2024-05-31 18:47 UTC2024-05A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-148072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-145c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-145c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-145d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-145d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-144b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-144b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078692-001CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY5MGTABLET, CHEWABLE / ORAL2008-02-1474a2ff9319b5…
2019-12-13 00:20 UTC2019-12A078692-002CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY10MGTABLET, CHEWABLE / ORALRS2008-02-1474a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cetirizine HydrochlorideCETIRIZINE HYDROCHLORIDESandoz Inc817d07cf-5e31-421f-9e95-943bae01f5b02025-06-30WarningsExact identifier
ndc (package): 0781-5283-64
ndc (package): 0781-5283-06
ndc (product): 0781-5283
ndc11 (package): 00781528306
ndc11 (package): 00781528364
spl id: 73150a55-d6f0-4ae0-847a-f9679694bf80
spl set id: 817d07cf-5e31-421f-9e95-943bae01f5b0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.